dc.creator | Diafas A., Toumanidou V., Kassos I., Samouilidou M., Dastiridou A., Ziakas N., Androudi S. | en |
dc.date.accessioned | 2023-01-31T07:54:28Z | |
dc.date.available | 2023-01-31T07:54:28Z | |
dc.date.issued | 2021 | |
dc.identifier | 10.1007/s10792-021-01918-7 | |
dc.identifier.issn | 01655701 | |
dc.identifier.uri | http://hdl.handle.net/11615/73254 | |
dc.description.abstract | Purpose: The purpose of this study is to report the clinical manifestations and treatment outcomes in three patients diagnosed with vasoproliferative tumors (VPTs). Methods: A retrospective, single-center case series was conducted, and retinal findings from three cases were documented by clinical examination and multimodal imaging. Results: Three patients presented with an elevated, yellow-white retinal lesion located at the peripheral retina and extensive retinal exudation. All three patients were closely monitored, and tumor-associated features included lipid exudates, cystoid macular edema (CMO), pre-retinal fibrosis and epi-retinal membrane (ERM). Clinical management relied on observation, cryotherapy, laser photocoagulation, intravitreal steroids and anti-vascular endothelial growth factor (anti-VEGF) treatment. Despite different clinical courses, two patients underwent vitreo-retinal surgery to address VPT-related complications of macular hole and vitreo-macular traction, whereas a patient underwent phacoemulsification to treat steroid-induced cataract. Conclusion: VPTs are uncommon benign vascular tumors and usually located at the infero-temporal peripheral retina. Close observation and early diagnosis of VPTs are of great importance in preventing vision-threatening complications and ensuring the best final visual outcome. The optimal treatment has yet to be defined due to lack of multi-center clinical studies. Despite the availability of less invasive therapeutic interventions, however, our case series show that pars plana vitrectomy is sometimes the most appropriate choice to restore visual acuity. © 2021, The Author(s), under exclusive licence to Springer Nature B.V. | en |
dc.language.iso | en | en |
dc.source | International Ophthalmology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108878450&doi=10.1007%2fs10792-021-01918-7&partnerID=40&md5=1d5d60095c6edec05860a1e5d3388a1f | |
dc.subject | bevacizumab | en |
dc.subject | dexamethasone | en |
dc.subject | lipid | en |
dc.subject | steroid | en |
dc.subject | adult | en |
dc.subject | apoptosis | en |
dc.subject | Article | en |
dc.subject | biomicroscopy | en |
dc.subject | case report | en |
dc.subject | clinical article | en |
dc.subject | cryotherapy | en |
dc.subject | epiretinal membrane | en |
dc.subject | female | en |
dc.subject | follow up | en |
dc.subject | human | en |
dc.subject | intraocular pressure | en |
dc.subject | laser coagulation | en |
dc.subject | macular edema | en |
dc.subject | male | en |
dc.subject | multimodal imaging | en |
dc.subject | optical coherence tomography | en |
dc.subject | pars plana vitrectomy | en |
dc.subject | perimetry | en |
dc.subject | phacoemulsification | en |
dc.subject | photodynamic therapy | en |
dc.subject | retina macula cystoid edema | en |
dc.subject | retrospective study | en |
dc.subject | slit lamp microscopy | en |
dc.subject | thermotherapy | en |
dc.subject | vascular tumor | en |
dc.subject | visual acuity | en |
dc.subject | visual field | en |
dc.subject | vitrectomy | en |
dc.subject | macular edema | en |
dc.subject | retina tear | en |
dc.subject | Humans | en |
dc.subject | Macular Edema | en |
dc.subject | Retinal Perforations | en |
dc.subject | Retrospective Studies | en |
dc.subject | Visual Acuity | en |
dc.subject | Vitrectomy | en |
dc.subject | Springer Science and Business Media B.V. | en |
dc.title | Macular sequelae in vasoproliferative tumors: results of surgical approach | en |
dc.type | journalArticle | en |